Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Spain Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20123
20143
20152
20168
20178
20183
20198
20206
202112
20223
20235
202411
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated18
Recruiting10
Unknown status10
Active, not recruiting5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals4
Novo Nordisk A/S4
Boehringer Ingelheim3
Tobira Therapeutics, Inc.3
89bio, Inc.2
AstraZeneca2
Eli Lilly and Company2
Fundació Eurecat2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease78
Liver Diseases15
Liver Cirrhosis14
Fibrosis13
Fatty Liver10
Obesity10
Metabolic Syndrome5
Digestive System Diseases4
Hypertension, Portal3
Overweight3

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.